23andMe Holding Co

ME

Company Profile

  • Business description

    23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

  • Contact

    349 Oyster Point Boulevard
    South San FranciscoCA94080
    USA

    T: +1 650 938-6300

    https://www.23andme.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 March 2025

    Employees

    582

Stocks News & Analysis

stocks

Ask the analyst: Can this big Covid loser scale its former heights?

Corporate Travel Management saw its profits fall through the floor during the pandemic. Our analyst Brian Han answers a reader question on what might be next.
stocks

Our view of BHP after reporting sales volumes

First half results largely met our expectations.
stocks

The fight for Insignia continues

Numerous acquisition proposals vindicate Insignia's improved earnings momentum.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,660.4031.300.36%
CAC 407,870.2857.34-0.72%
DAX 4021,175.12219.81-1.03%
Dow JONES (US)44,424.25140.82-0.32%
FTSE 1008,488.6613.69-0.16%
HKSE20,197.77131.580.66%
NASDAQ19,954.3099.38-0.50%
Nikkei 22539,565.80366.18-0.92%
NZX 50 Index12,999.7224.98-0.19%
S&P 5006,101.2417.47-0.29%
S&P/ASX 2008,408.9030.200.36%
SSE Composite Index3,250.602.03-0.06%

Market Movers